The ApoB/ApoA1 ratio test compares two major blood proteins involved in cholesterol transport. ApoB is found on particles that can enter artery walls and contribute to plaque, including LDL, VLDL, IDL, remnants, and lipoprotein(a). ApoA1 is the main protein on HDL particles, which are involved in reverse cholesterol transport and other protective functions. A higher ratio means there is more ApoB-driven, plaque-forming particle burden relative to ApoA1-related HDL activity.
This ratio can add useful detail when a standard cholesterol panel looks “borderline,” when triglycerides are high, when metabolic syndrome or diabetes is present, or when someone has a strong family history of early heart disease. It does not diagnose a heart attack or blocked artery by itself. It helps place lipid results into a broader cardiovascular risk picture, especially when interpreted with LDL cholesterol, non-HDL cholesterol, triglycerides, ApoB, ApoA1, blood pressure, glucose markers, smoking status, kidney function, and personal history.
- The ApoB/ApoA1 ratio measures the balance between plaque-forming ApoB particles and ApoA1-rich HDL-related protection.
- A lower ApoB/ApoA1 ratio is generally better; higher values are linked with higher atherosclerotic cardiovascular risk.
- Common adult risk categories are lower risk below 0.7 in men and below 0.6 in women, with higher risk above 0.9 in men and above 0.8 in women.
- A high ratio can come from high ApoB, low ApoA1, or both, so the separate ApoB and ApoA1 values matter.
- Fasting is usually not required for ApoB and ApoA1 alone, but fasting may be requested if the test is ordered with a lipid panel.
- Abnormal results usually call for cardiovascular risk review, not emergency care, unless symptoms such as chest pain, severe shortness of breath, or stroke signs are present.
Table of Contents
- What the ApoB/ApoA1 Ratio Measures
- Normal Range and Risk Categories
- What a High ApoB/ApoA1 Ratio Means
- What a Low ApoB/ApoA1 Ratio Means
- Cardiovascular Risk and Lipid Results
- Testing, Preparation, and Result Timing
- How to Improve the ApoB/ApoA1 Ratio
- Questions to Ask About Your Results
What the ApoB/ApoA1 Ratio Measures
The ApoB/ApoA1 ratio is calculated by dividing apolipoprotein B by apolipoprotein A1. Both proteins are measured in blood, usually in mg/dL, but the ratio itself is reported as a unitless number. For example, an ApoB of 100 mg/dL and an ApoA1 of 140 mg/dL gives a ratio of 0.71.
ApoB is the main structural protein on atherogenic lipoproteins, meaning particles that can promote atherosclerosis. Atherosclerosis is the gradual buildup of cholesterol-rich plaque inside artery walls. Each LDL, IDL, VLDL remnant, and Lp(a) particle carries one ApoB protein, so ApoB gives a close estimate of the number of artery-entering particles in circulation. This is why a separate ApoB blood test can sometimes identify risk that LDL cholesterol alone misses.
ApoA1 is the main protein on HDL particles. HDL is often called “good cholesterol,” but HDL cholesterol only measures how much cholesterol is carried within HDL particles. ApoA1 gives a different view: it reflects a major structural and functional component of HDL. ApoA1 helps form HDL particles and supports cholesterol movement away from tissues toward the liver. A separate ApoA1 test can be helpful when HDL cholesterol is low, very high, or difficult to interpret.
The ratio combines both sides into one comparison. A high ratio usually means one of three patterns:
- ApoB is high while ApoA1 is normal.
- ApoA1 is low while ApoB is normal.
- ApoB is high and ApoA1 is low at the same time.
The third pattern is often the most concerning because it suggests a high burden of plaque-forming particles plus weaker HDL-related protection. This pattern is common in insulin resistance, high triglycerides, abdominal obesity, smoking, type 2 diabetes, and some inherited lipid disorders.
The ratio should not replace the separate values. Two people can have the same ratio for different reasons. A person with ApoB 90 mg/dL and ApoA1 150 mg/dL has a ratio of 0.60. Another person with ApoB 60 mg/dL and ApoA1 100 mg/dL also has a ratio of 0.60, but the second person has low ApoA1 and needs a different discussion. The ratio is most useful when it is read beside ApoB, ApoA1, LDL cholesterol, HDL cholesterol, non-HDL cholesterol, triglycerides, and clinical risk factors.
Normal Range and Risk Categories
ApoB/ApoA1 ratio ranges vary by laboratory, age, sex, method, and population. Always compare your result with the reference interval printed on your own lab report. Still, many clinical labs use sex-specific adult categories because women often have higher ApoA1 levels and lower ratios than men, especially before menopause.
| Group | Lower-risk range | Average-risk range | Higher-risk range |
|---|---|---|---|
| Adult men | <0.7 | 0.7–0.9 | >0.9 |
| Adult women | <0.6 | 0.6–0.8 | >0.8 |
These categories are risk categories, not disease labels. A ratio of 0.92 in a man does not prove that he has coronary artery disease. It does mean his ApoB-to-ApoA1 balance is in a range associated with higher cardiovascular risk and should be interpreted with his full risk profile.
For children and teenagers, some laboratories use an ApoB/ApoA1 ratio below 0.8 as an acceptable result from ages 2 to 17. Pediatric interpretation should be cautious because inherited lipid disorders, obesity, type 2 diabetes, kidney disease, and family history can change the meaning of the result.
The separate ApoB and ApoA1 results are just as important as the ratio. A typical adult lab report may classify ApoB below 90 mg/dL as desirable, 90–99 mg/dL as above desirable, 100–119 mg/dL as borderline high, 120–139 mg/dL as high, and 140 mg/dL or higher as very high. ApoA1 is often expected to be at least 120 mg/dL in adult men and at least 140 mg/dL in adult women, though reference intervals differ by lab.
A ratio near the cutoff needs context. For example, a 55-year-old man with a ratio of 0.72, normal blood pressure, no diabetes, no smoking, and no family history may need routine prevention advice. A 55-year-old man with the same ratio plus diabetes, high triglycerides, low HDL cholesterol, and a father who had a heart attack at 48 may need more aggressive risk evaluation. The number is useful because it sharpens the conversation, not because it decides treatment alone.
What a High ApoB/ApoA1 Ratio Means
A high ApoB/ApoA1 ratio means the blood contains a less favorable balance between atherogenic ApoB particles and ApoA1-related HDL function. In plain language, the “plaque-forming particle” side is too strong compared with the HDL-related side.
The most common reason is high ApoB. ApoB rises when the number of atherogenic particles increases. This can happen even when LDL cholesterol does not look severely high, because LDL cholesterol measures cholesterol mass, while ApoB reflects particle number. Small cholesterol-poor LDL particles can create a high ApoB result with only modest LDL cholesterol. This pattern often appears with high triglycerides, low HDL cholesterol, insulin resistance, and fatty liver.
A high ratio can also come from low ApoA1. Low ApoA1 may reflect low HDL particle production, poor metabolic health, smoking, inflammation, liver disease, poorly controlled diabetes, obesity, or certain genetic conditions. HDL cholesterol and ApoA1 are related, but they are not the same measurement. Some people have a normal HDL cholesterol value but less favorable HDL particle function or ApoA1 status.
Common causes and contributors include:
- Insulin resistance or type 2 diabetes
- Metabolic syndrome, especially abdominal obesity with high triglycerides
- Familial combined hyperlipidemia or familial hypercholesterolemia
- High intake of saturated fat or trans fat in susceptible people
- Smoking or heavy exposure to tobacco smoke
- Sedentary lifestyle
- Hypothyroidism
- Chronic kidney disease or nephrotic syndrome
- Fatty liver disease
- Pregnancy, which can raise some lipid markers
- Some medications, depending on the person and clinical setting
A high ratio is especially important when it appears with other abnormal markers. High triglycerides, high non-HDL cholesterol, high LDL cholesterol, high Lp(a), elevated blood pressure, high fasting glucose, elevated HbA1c, and a strong family history all add weight to the finding. In that setting, an advanced lipid panel may help clarify whether the main issue is ApoB particle number, Lp(a), remnant cholesterol, LDL particle number, small dense LDL, or a broader metabolic pattern.
A high result should not be ignored just because total cholesterol is “not too bad.” Total cholesterol can hide different risk patterns because it includes LDL cholesterol, HDL cholesterol, and cholesterol carried in triglyceride-rich particles. A person with high HDL cholesterol may have a reassuring total cholesterol/HDL ratio but still have high ApoB or high Lp(a). The ApoB/ApoA1 ratio can reveal this imbalance more clearly.
What a Low ApoB/ApoA1 Ratio Means
A low ApoB/ApoA1 ratio is usually favorable because it means ApoB particle burden is low relative to ApoA1. Many people with a low ratio have low ApoB, healthy triglycerides, good insulin sensitivity, no smoking exposure, regular physical activity, and a dietary pattern low in trans fat and moderate in saturated fat.
A low ratio can also result from treatment. Statins, ezetimibe, PCSK9 inhibitors, bempedoic acid, and other lipid-lowering therapies can reduce ApoB by lowering the number of circulating atherogenic particles. When ApoB falls and ApoA1 is stable, the ratio improves.
Still, very low results deserve context. A very low ApoB can occur with intensive lipid-lowering treatment, but it can also occur with malnutrition, significant liver disease, severe illness, or inherited hypobetalipoproteinemia. Low ApoA1 can remain a concern even when the ratio looks acceptable, especially if both ApoB and ApoA1 are low. The ratio can look “good” mathematically while one component still needs attention.
A lower ratio also does not erase all cardiovascular risk. Blood pressure, smoking, diabetes, chronic kidney disease, inflammatory disease, age, prior heart attack or stroke, and high Lp(a) can still raise risk. A person with low ApoB/ApoA1 but very high lipoprotein(a) may still need a careful prevention plan because Lp(a) is genetically driven and carries risk beyond standard cholesterol measures.
Low ApoB/ApoA1 is best understood as one favorable sign within a wider risk profile. It often supports a less atherogenic lipid pattern, but it should be interpreted with symptoms, history, medications, diet, weight change, liver markers, thyroid status, and the rest of the lipid report.
Cardiovascular Risk and Lipid Results
The ApoB/ApoA1 ratio is useful because atherosclerosis depends heavily on the number of particles that can enter the artery wall and remain there over time. ApoB-containing particles can cross into the artery lining, become retained, and trigger inflammation. Over years, this process can produce plaque that narrows arteries or ruptures suddenly, causing a heart attack or stroke.
LDL cholesterol remains a central treatment marker in many guidelines, but LDL cholesterol and ApoB can disagree. LDL cholesterol measures the cholesterol content inside LDL particles. ApoB estimates the total number of atherogenic particles. When particles carry less cholesterol each, LDL cholesterol can look less alarming than the particle burden really is. This often happens in people with high triglycerides, diabetes, obesity, metabolic syndrome, and low HDL cholesterol.
Non-HDL cholesterol is another useful marker because it includes cholesterol carried by all atherogenic particles, not only LDL. It is calculated as total cholesterol minus HDL cholesterol. A high non-HDL cholesterol result often tracks with high ApoB, especially when triglycerides are elevated. When ApoB and non-HDL cholesterol are both high, the message is usually straightforward: atherogenic particle burden is too high.
The ApoB/ApoA1 ratio can be especially helpful in several situations:
- LDL cholesterol is normal or mildly high, but there is a strong family history of early cardiovascular disease.
- Triglycerides are high and HDL cholesterol is low.
- Diabetes, prediabetes, insulin resistance, or metabolic syndrome is present.
- A person has had a heart attack, stroke, stent, bypass surgery, or peripheral artery disease.
- Standard lipid results do not match the person’s clinical risk.
- Treatment decisions require a clearer view of residual lipid risk.
The ratio also has limits. It does not show whether plaque is already present. It does not replace symptoms, physical examination, blood pressure, diabetes testing, kidney function, or imaging when imaging is needed. It also should not be used as the only treatment target. Many clinicians place more emphasis on ApoB itself because lowering ApoB directly lowers the concentration of particles that drive atherosclerosis.
For practical interpretation, the ratio answers a different question than a standard lipid panel. The lipid panel shows cholesterol and triglyceride concentrations. ApoB/ApoA1 shows the balance between particle burden and ApoA1-related HDL biology. Together, they provide a more complete picture than either one alone.
Testing, Preparation, and Result Timing
The ApoB/ApoA1 ratio test is a blood test. A blood sample is usually taken from a vein in the arm. The lab measures ApoB and ApoA1, then reports the calculated ratio. Some reports show all three numbers: ApoB, ApoA1, and ApoB/ApoA1 ratio. Others may show only the ratio if the test was ordered that way, but having the separate values is more useful.
Fasting is usually not required for ApoB and ApoA1 alone because these proteins are relatively stable after meals. However, fasting may be requested when the test is ordered with triglycerides, LDL cholesterol calculation, glucose, insulin, or a broader metabolic panel. Many clinics still ask for a 9- to 12-hour fast before a combined lipid and metabolic blood draw because it reduces confusion when triglycerides are high.
Before the test, follow the instructions on the lab order. Do not stop prescribed medicines unless the ordering clinician tells you to. If you take lipid-lowering therapy, the result reflects your treated level, which is often exactly what the clinician wants to know. If the purpose is to estimate untreated baseline risk, the clinician may interpret the result differently or review older records.
Results often return within a few business days, though timing varies by lab. ApoB and ApoA1 are sometimes sent to a reference lab, so they may take longer than a standard cholesterol panel.
Several issues can affect interpretation:
- Recent major illness, surgery, or hospitalization can temporarily change lipid markers.
- Pregnancy changes lipid metabolism and can raise ApoB-containing particles.
- Thyroid disease can raise LDL cholesterol and ApoB when untreated.
- Kidney disease, especially nephrotic syndrome, can raise ApoB.
- Liver disease can lower ApoA1 and sometimes lower ApoB.
- Very rare blood protein disorders can interfere with some laboratory methods.
Repeating the test may make sense if the result does not fit the clinical picture, if there was recent illness, or if a major treatment change was made. Lipid-lowering medication changes are often reassessed after about 4 to 12 weeks, depending on the drug, the clinical situation, and local practice.
How to Improve the ApoB/ApoA1 Ratio
Improving the ApoB/ApoA1 ratio usually means lowering ApoB, raising or preserving ApoA1, and treating the metabolic drivers that push the ratio upward. In most people, the largest and most reliable improvement comes from lowering ApoB particle burden.
Food choices can help. Replacing butter, high-fat processed meats, full-fat dairy, coconut oil, palm oil, and fried fast foods with unsaturated fats from olive oil, nuts, seeds, avocado, and fish can reduce LDL-related particle burden in many people. Soluble fiber from oats, barley, beans, lentils, psyllium, vegetables, and fruit can also lower LDL cholesterol and ApoB. Reducing trans fat is important because trans fat can raise ApoB-containing particles and lower HDL-related markers.
Weight loss can improve the ratio when excess visceral fat, insulin resistance, and high triglycerides are present. Even a 5% to 10% reduction in body weight can improve triglycerides, HDL cholesterol, glucose, insulin resistance, and fatty liver markers in many people. The benefit is often strongest when weight loss comes from a sustainable pattern that includes higher-fiber carbohydrates, adequate protein, unsaturated fats, and fewer refined starches and sugary drinks.
Physical activity helps in several ways. Aerobic exercise can lower triglycerides, improve insulin sensitivity, and modestly raise HDL-related markers. Resistance training supports muscle mass and glucose handling. A useful target for many adults is at least 150 minutes per week of moderate-intensity aerobic activity plus 2 sessions per week of resistance training, adjusted for fitness level and medical conditions.
Smoking cessation can improve HDL-related biology and reduce vascular inflammation. Smoking is especially harmful because it affects lipids, blood vessels, clotting, oxidation, and inflammation at the same time. A person with a high ApoB/ApoA1 ratio who smokes often has more to gain from quitting than from focusing on small dietary details alone.
Medications may be needed when ApoB is high, when cardiovascular risk is high, or when lifestyle changes are not enough. Statins are commonly used first because they lower LDL cholesterol, ApoB, and cardiovascular event risk. Ezetimibe, PCSK9 inhibitors, inclisiran, bempedoic acid, fibrates, prescription omega-3 therapy, and other treatments may be considered depending on the lipid pattern and risk level. Treatment should focus on the person’s overall risk, not only the ratio.
Metabolic health deserves special attention. High triglycerides, low HDL cholesterol, elevated waist circumference, high fasting glucose, high fasting insulin, and elevated HbA1c often travel together. When this pattern is present, improving insulin sensitivity can lower ApoB/ApoA1 and improve related markers. Testing such as HbA1c, fasting glucose, fasting insulin, or a HOMA-IR score may help clarify the metabolic side of the problem.
Questions to Ask About Your Results
ApoB/ApoA1 ratio results are most useful when they lead to specific next steps. Bring the full report, not only the ratio, to the appointment. The ApoB, ApoA1, LDL cholesterol, HDL cholesterol, triglycerides, non-HDL cholesterol, and any advanced markers can change the interpretation.
Helpful questions include:
- Is my ratio high because ApoB is high, ApoA1 is low, or both?
- How does this result change my estimated cardiovascular risk?
- Are my LDL cholesterol and ApoB telling the same story, or do they disagree?
- Should I have Lp(a), hs-CRP, HbA1c, thyroid testing, kidney testing, or liver testing checked?
- Do my results suggest insulin resistance, metabolic syndrome, or an inherited lipid disorder?
- What ApoB or LDL cholesterol target makes sense for my risk level?
- Should I repeat the test after lifestyle changes or medication adjustment?
- Would coronary artery calcium scoring or another form of imaging be useful in my situation?
Some results deserve more urgent attention because of symptoms, not because of the ratio itself. Seek urgent medical care for chest pressure, chest pain spreading to the arm or jaw, severe shortness of breath, fainting, sudden weakness on one side, sudden speech trouble, sudden vision loss, or severe unexplained sweating with nausea. The ApoB/ApoA1 ratio is a prevention and risk-assessment marker; it is not a test for ruling out a current heart attack or stroke.
For many people, the most useful follow-up is a structured prevention plan. That plan may include nutrition changes, exercise, smoking cessation, blood pressure control, diabetes prevention or treatment, sleep apnea evaluation, medication, and repeat testing. If triglycerides are high, the triglyceride/HDL ratio can add clues about insulin resistance. If inflammation is part of the concern, hs-CRP testing may provide another layer of risk information.
The ApoB/ApoA1 ratio is strongest when it moves the discussion from vague cholesterol labels toward measurable risk drivers. A high ratio points toward excess atherogenic particle burden, low ApoA1-related protection, or both. A lower ratio is usually reassuring, but it still belongs inside a full cardiovascular risk assessment.
References
- Role of apolipoprotein B in the Clinical Management of Cardiovascular Risk in Adults: An Expert Clinical Consensus from the National Lipid Association 2024 (Position Statement)
- 2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias 2025 (Guideline)
- ADLM Guidance Document on the Measurement and Reporting of Lipids and Lipoproteins 2024 (Guidance)
- APOAB – Overview: Apolipoprotein A1 and B, Serum 2026 (Laboratory Reference)
- Revisiting an old relationship: the causal associations of the ApoB/ApoA1 ratio with cardiometabolic diseases and relative risk factors—a mendelian randomization analysis 2024 (Mendelian Randomization Study)
- ApoB/ApoA-Ι is associated with major cardiovascular events and readmission risk of patients after percutaneous coronary intervention in one year 2025 (Study)
Disclaimer
The ApoB/ApoA1 ratio is a cardiovascular risk marker, not a diagnosis by itself. Reference ranges and treatment targets can vary by laboratory, age, sex, medical history, and medication use. Discuss abnormal results with a qualified healthcare professional, especially if you have diabetes, kidney disease, prior heart attack or stroke, very high cholesterol, high Lp(a), or a family history of early cardiovascular disease.
